References

An, D., G. Kewalramani, J.K. Chan, D. Qi and S. Ghosh et al., 2006. Metformin influence cardiomyocyte cell death by pathway that are dependent and independent of caspase-3. Diabetologia, 49: 2174-2184.
PubMed  |  

Bhamra, G.S., D.J. Hausenloy, S.M. Davidson, R.D. Carr and M. Paiva et al., 2008. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res. Cardiol., 103: 274-284.
CrossRef  |  PubMed  |  

Calvert, J.W., S. Gundewar, S. Jha, J.J.M. Greer, W.H. Bestermann, R. Tian and D.J. Lefer, 2008. Acute metformin therapyconfers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes, 57: 696-705.
CrossRef  |  

Dyck, J.R. and G.D. Lopaschuk, 2006. AMPK alterations in cardiac physiology and pathology: Enemy or ally? J. Physiol., 574: 95-112.
PubMed  |  

Frangogiannis, N.G., C.W. Smith and M.L. Entman, 2002. The inflammatory response in myocardial infarction. Cardiovas Res., 53: 31-47.
CrossRef  |  

Garjani, A., C.L. Wainwright, I.J. Zeitlin, C. Wilson and S.J. Slee, 1995. Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. J. Cardiovasc Pharmacol., 25: 634-642.
PubMed  |  

Gottlieb R.A. and R.L. Engler, 1999. Apoptosis in myocardial ischemia-reperfusion. Ann. N. Y. Acad Sci., 874: 412-426.
CrossRef  |  

Gundewar, S., J.W. Calvert, S. Jha, I. Toedt-Pingel and S.Y. Ji et al., 2009. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ. Res., 104: 403-411.
PubMed  |  

Hardie, D.G. and D. Carling, 1997. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem., 246: 259-273.
PubMed  |  

Jermendy, G., 2010. New clinical data with metformin therapy in patients with diabetes mellitus. Orv. Hetil., 151: 2025-2030.

Legtenberg, R.J., R.J. Houston, B. Oeseburg and P. Smits, 2002. Metformin improves cardiac functional recovery after ischemia in rats. Horm Metab. Res., 34: 182-185.
PubMed  |  

Paiva, M., N.P. Riksen, S.M. Davidson, D.J. Hausenloy and P. Monteiro et al., 2009. Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J. Cardiovasc. Pharmacol., 53: 373-378.
PubMed  |  

Russell, R.R., J. Li, D.L. Coven, M. Pypaert and C. Zechner et al., 2004. AMP activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis and injury. J. Clin. Invest., 114: 495-503.
PubMed  |  

Sasaki, H., H. Asanuma, M. Fujita, H. Takahama and M. Wakeno et al., 2009. Metformin prevents progression of heart failure in dogs: Role of AMP-activated protein kinase. Circulation, 119: 2568-2577.
PubMed  |  

Solskov, L., B. Lofgren, S.B. Kristiansen, N. Jessen and R. Pold et al., 2008. Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration. Basic Clin. Pharmacol. Toxicol., 103: 82-87.
CrossRef  |  PubMed  |  Direct Link  |  

Su, R.Y., Y. Chao, T.Y. Chen, D.Y. Huang and W.W. Lin, 2007. 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNFα-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling. Mol. Cancer Ther., 6: 1562-1571.
PubMed  |